“Myocardial Salvaging Effects and Mechanisms of Dipeptidyl Peptidase-IV Inhibitor Vildagliptin in Experimental Diabetes”. International Journal of Biomedical Research, vol. 7, no. 5, May 2016, pp. 276-82, https://doi.org/10.7439/ijbr.v7i5.3273.